A detailed history of Susquehanna International Group, LLP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 110,175 shares of SRPT stock, worth $11.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110,175
Previous 194,794 43.44%
Holding current value
$11.5 Million
Previous $30.8 Million 55.29%
% of portfolio
0.0%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$124.33 - $156.75 $10.5 Million - $13.3 Million
-84,619 Reduced 43.44%
110,175 $13.8 Million
Q2 2024

Aug 15, 2024

SELL
$113.33 - $163.85 $9.85 Million - $14.2 Million
-86,903 Reduced 30.85%
194,794 $30.8 Million
Q1 2024

May 07, 2024

BUY
$93.7 - $141.53 $14.6 Million - $22.1 Million
156,096 Added 124.28%
281,697 $36.5 Million
Q4 2023

Feb 14, 2024

SELL
$67.31 - $124.76 $992,149 - $1.84 Million
-14,740 Reduced 10.5%
125,601 $12.1 Million
Q3 2023

Nov 14, 2023

SELL
$102.5 - $123.59 $9.74 Million - $11.7 Million
-95,020 Reduced 40.37%
140,341 $17 Million
Q2 2023

Aug 11, 2023

BUY
$106.4 - $157.19 $10.2 Million - $15 Million
95,534 Added 68.32%
235,361 $27 Million
Q1 2023

May 16, 2023

BUY
$117.53 - $155.99 $3.75 Million - $4.97 Million
31,880 Added 29.53%
139,827 $19.3 Million
Q4 2022

Feb 14, 2023

BUY
$100.86 - $132.13 $5.28 Million - $6.91 Million
52,331 Added 94.09%
107,947 $14 Million
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $4 Million - $6.3 Million
52,824 Added 1891.98%
55,616 $6.15 Million
Q2 2022

Aug 15, 2022

SELL
$62.69 - $88.44 $875,528 - $1.24 Million
-13,966 Reduced 83.34%
2,792 $209,000
Q1 2022

May 16, 2022

SELL
$63.15 - $90.42 $20.3 Million - $29.1 Million
-321,659 Reduced 95.05%
16,758 $1.31 Million
Q4 2021

Feb 14, 2022

BUY
$77.28 - $99.42 $131,221 - $168,815
1,698 Added 0.5%
338,417 $30.5 Million
Q3 2021

Nov 15, 2021

BUY
$65.97 - $92.48 $9.03 Million - $12.7 Million
136,888 Added 68.5%
336,719 $31.1 Million
Q2 2021

Aug 11, 2021

SELL
$69.38 - $86.75 $2.89 Million - $3.62 Million
-41,689 Reduced 17.26%
199,831 $15.5 Million
Q1 2021

May 17, 2021

BUY
$72.25 - $168.95 $7.08 Million - $16.5 Million
97,927 Added 68.2%
241,520 $18 Million
Q4 2020

Feb 16, 2021

BUY
$125.56 - $178.74 $8.85 Million - $12.6 Million
70,462 Added 96.35%
143,593 $24.5 Million
Q3 2020

Nov 16, 2020

BUY
$127.12 - $172.34 $5.63 Million - $7.63 Million
44,255 Added 153.26%
73,131 $10.3 Million
Q2 2020

Aug 14, 2020

SELL
$93.0 - $171.7 $5.97 Million - $11 Million
-64,219 Reduced 68.98%
28,876 $4.63 Million
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $7.07 Million - $11.3 Million
-85,834 Reduced 47.97%
93,095 $9.11 Million
Q4 2019

Feb 14, 2020

SELL
$76.53 - $135.58 $29.1 Million - $51.5 Million
-379,710 Reduced 67.97%
178,929 $23.1 Million
Q3 2019

Nov 14, 2019

BUY
$72.81 - $156.91 $14.6 Million - $31.4 Million
200,313 Added 55.9%
558,639 $42.1 Million
Q2 2019

Aug 16, 2019

BUY
$112.21 - $151.95 $2.01 Million - $2.72 Million
17,875 Added 5.25%
358,326 $54.4 Million
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $12.4 Million - $16.8 Million
110,441 Added 48.02%
340,451 $51.7 Million
Q1 2019

May 15, 2019

SELL
$106.67 - $151.68 $11 Million - $15.6 Million
-102,667 Reduced 30.86%
230,010 $27.4 Million
Q4 2018

Feb 14, 2019

SELL
$97.32 - $148.76 $13.7 Million - $21 Million
-140,983 Reduced 29.76%
332,677 $36.3 Million
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $53.4 Million - $74.8 Million
-463,422 Reduced 49.45%
473,660 $76.5 Million
Q2 2018

Aug 14, 2018

BUY
$71.74 - $153.69 $45.2 Million - $96.9 Million
630,493 Added 205.65%
937,082 $124 Million
Q1 2018

May 15, 2018

SELL
$54.02 - $82.27 $46.9 Million - $71.4 Million
-868,215 Reduced 73.9%
306,589 $22.7 Million
Q4 2017

Feb 14, 2018

BUY
$47.64 - $56.75 $8.06 Million - $9.6 Million
169,159 Added 16.82%
1,174,804 $65.4 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $35.9 Million - $47.4 Million
1,005,645
1,005,645 $45.6 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.15B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.